Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Scope of the Report:
North America is the largest supplier of Blood Product, with production revenue market share about 60%, and the sales market share is 40% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20%. China is an important market of Blood Product in Asia, accounting for 9% production revenue market share and 14% sales revenue market share of global market.
Japan has equal production revenue market share and sales revenue market share nearly. The local production can meet most local demand, and there is a small amount of imports.
The global Blood Product market is valued at 26100 million USD in 2018 and is expected to reach 47800 million USD by the end of 2024, growing at a CAGR of 10.6% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Blood Product.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Blood Product market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Blood Product market by product type and applications/end industries.
Market Segment by Companies, this report covers
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Albumin
Immune Globulin
Coagulation Factor
Others
Market Segment by Applications, can be divided into
Immunity
Therapy
Surgery
Other
Scope of the Report:
North America is the largest supplier of Blood Product, with production revenue market share about 60%, and the sales market share is 40% in 2015. That is to say, there are a large number of exports in North America, while North America also is the largest consumption region.
Europe, following North America, takes production revenue market share of 20% and the sales market share over 20%. China is an important market of Blood Product in Asia, accounting for 9% production revenue market share and 14% sales revenue market share of global market.
Japan has equal production revenue market share and sales revenue market share nearly. The local production can meet most local demand, and there is a small amount of imports.
The global Blood Product market is valued at 26100 million USD in 2018 and is expected to reach 47800 million USD by the end of 2024, growing at a CAGR of 10.6% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Blood Product.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Blood Product market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Blood Product market by product type and applications/end industries.
Market Segment by Companies, this report covers
Baxter
CSL
Grifols
Octapharma
BPL
Kedrion
Mitsubishi Tanabe
CBOP
RAAS
Hualan Bio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Albumin
Immune Globulin
Coagulation Factor
Others
Market Segment by Applications, can be divided into
Immunity
Therapy
Surgery
Other
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
